Epredia is a global precision cancer diagnostics company founded in 2019, focused on providing technologies for anatomical pathology laboratories. The company offers a comprehensive range of solutions spanning specimen preparation, tissue processing, slide printing, and digital pathology. Its product portfolio draws on legacy brands including Shandon, Microm, Menzel Gläser, and Richard-Allan Scientific.
The company operates at significant scale: its products are employed 48 times per second across every hour of the day, and customers trust Epredia over a billion times each year. Its technologies serve anatomical pathology laboratories and cancer diagnostics workflows worldwide, positioning the company as a key infrastructure provider in the pathology sector.
Epredia's stated mission centres on improving lives by enhancing precision cancer diagnostics. The company emphasises personal commitment to pathology professionals and customer support as core elements of its operating approach.
